8-K Announcements
6Material company update
Apr 30, 2026·SEC
Material company update
Apr 1, 2026·SEC
Material company update
Mar 10, 2026·SEC
The Clorox Company(CLX)Earnings, Financials & Key Ratios
CLX•NYSE
14.7× P/E·Price updated Jun 19, 2026
AboutThe Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; natural personal care products under the Burt's Bees brand; and water-filtration products under the Brita brand in the United States. The International segment provides laundry additives; home care products; water-filtration systems; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brands. The Clorox Company sells its products primarily through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force The company was founded in 1913 and is headquartered in Oakland, California.Show more
- Revenue$7.1B+0.2%
- EBITDA$1.4B+21.5%
- Net Income$810M+189.3%
- EPS (Diluted)6.52+189.8%
- Gross Margin44.96%+5.4%
- EBITDA Margin19.68%+21.3%
- Operating Margin16.6%+28.5%
- Net Margin11.4%+188.8%
- ROE166.32%+161.4%
CLX Key Insights
The Clorox Company (CLX) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Dividend Aristocrat: 42 years of consecutive increases
- ✓Excellent 3Y average ROE of 85.5%
- ✓Strong Piotroski F-Score: 7/9
- ✓High quality earnings: Operating CF exceeds net income
- ✓Healthy dividend yield of 5.1%
- ✓Efficient asset utilization: 1.3x turnover
✗Weaknesses
- ✗High debt to equity ratio of 6.0x
- ✗Expensive at 24.7x book value
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when CLX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
CLX Price & Volume
The Clorox Company (CLX) stock price & volume — 10-year historical chart
Loading chart...
CLX Growth Metrics
The Clorox Company (CLX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years2.31%
5 Years1.11%
3 Years-0.01%
TTM-3.69%
Profit CAGR
10 Years3.4%
5 Years-2.91%
3 Years20.58%
TTM8.93%
EPS CAGR
10 Years4.08%
5 Years-2.37%
3 Years20.46%
TTM10.79%
Return on Capital
10 Years28.53%
5 Years23.11%
3 Years24.06%
Last Year30.16%
CLX Recent Earnings
The Clorox Company (CLX) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
Apr 30, 2026Metric
Actual
Est
EPS
$1.64+6.5%
$1.54
Rev
$1.7B+0.0%
$1.7B
Q1 2026
Feb 3, 2026Metric
Actual
Est
EPS
$1.39-2.8%
$1.43
Rev
$1.7B+2.0%
$1.6B
Q4 2025
Nov 3, 2025Metric
Actual
Est
EPS
$0.85+3.9%
$0.82
Rev
$1.4B+2.1%
$1.4B
Q3 2025
Jul 31, 2025Metric
Actual
Est
EPS
$2.87+30.5%
$2.20
Rev
$2.0B+3.1%
$1.9B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $1.64vs $1.54+6.5% | $1.7Bvs $1.7B+0.0% |
| Q1 2026 | Feb 3, 2026 | $1.39vs $1.43-2.8% | $1.7Bvs $1.6B+2.0% |
| Q4 2025 | Nov 3, 2025 | $0.85vs $0.82+3.9% | $1.4Bvs $1.4B+2.1% |
| Q3 2025 | Jul 31, 2025 | $2.87vs $2.20+30.5% | $2.0Bvs $1.9B+3.1% |
Based on last 12 quarters of dataView full earnings history →
CLX Peer Comparison
The Clorox Company (CLX) competitors in Household Cleaning and Paper Goods — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 CHD | 22.65B | 95.64 | 31.67 | 1.57% | 11.81% | 17.45% | 0.55 | |
 SPB | 1.95B | 83.97 | 21.75 | -5.23% | 4.48% | 6.65% | 0.34 | |
 ENR | 1.47B | 21.52 | 6.48 | 2.28% | 6.55% | 116.9% | 20.79 | |
 RCKY | 314.22M | 41.67 | 14.08 | 6.22% | 4.62% | 9.15% | 0.49 | |
 PG | 351.4B | 150.38 | 23.10 | 0.29% | 14.66% | 23.78% | 0.68 | |
 KMB | 34.04B | 102.56 | 16.90 | -14.17% | 12.81% | 131.68% | 4.34 | |
 COTY | 1.72B | 1.95 | -4.43 | -3.68% | -9.26% | -14.13% | 1.07 | |
 EPC | 1.06B | 23.11 | 43.60 | -1.34% | -3.69% | -5.14% | 0.99 |
Compare CLX vs Peers
The Clorox Company (CLX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CLX Income Statement
The Clorox Company (CLX) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 5.97B | 6.12B | 6.21B | 6.72B | 7.34B | 7.11B | 7.39B | 7.09B | 7.1B | 6.76B |
Revenue Growth % | 3.68% | 2.53% | 1.47% | 8.16% | 9.22% | -3.19% | 3.97% | -4.01% | 0.16% | -3.69% |
Cost of Goods Sold | 3.31B | 3.46B | 3.5B | 3.67B | 4.16B | 4.62B | 4.52B | 4.07B | 3.91B | 3.8B |
COGS % of Revenue | 55.37% | 56.5% | 56.37% | 54.56% | 56.67% | 64.95% | 61.14% | 57.35% | 55.04% | - |
Gross Profit | 2.67B▲ 0% | 2.66B▼ 0.1% | 2.71B▲ 1.8% | 3.05B▲ 12.7% | 3.18B▲ 4.2% | 2.49B▼ 21.7% | 2.87B▲ 15.3% | 3.02B▲ 5.4% | 3.19B▲ 5.6% | 2.96B▲ 0% |
Gross Margin % | 44.63% | 43.5% | 43.63% | 45.44% | 43.33% | 35.05% | 38.86% | 42.65% | 44.96% | 43.77% |
Gross Profit Growth % | 2.46% | -0.07% | 1.76% | 12.65% | 4.16% | -21.69% | 15.25% | 5.36% | 5.59% | - |
Operating Expenses | 1.54B | 1.54B | 1.6B | 1.79B | 1.94B | 1.79B | 2.04B | 2.11B | 2.02B | 1.88B |
OpEx % of Revenue | 25.85% | 25.13% | 25.81% | 26.62% | 26.47% | 25.26% | 27.66% | 29.73% | 28.36% | - |
Selling, General & Admin | 1.41B | 1.41B | 1.47B | 1.64B | 1.79B | 1.66B | 1.91B | 1.98B | 1.89B | 1.77B |
SG&A % of Revenue | 23.59% | 22.98% | 23.62% | 24.46% | 24.44% | 23.4% | 25.78% | 27.96% | 26.66% | - |
Research & Development | 135M | 132M | 136M | 145M | 149M | 132M | 138M | 126M | 121M | 116M |
R&D % of Revenue | 2.26% | 2.16% | 2.19% | 2.16% | 2.03% | 1.86% | 1.87% | 1.78% | 1.7% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | 1.12B▲ 0% | 1.13B▲ 0.3% | 1.11B▼ 1.6% | 1.26B▲ 14.3% | 1.24B▼ 2.1% | 696M▼ 43.8% | 827M▲ 18.8% | 916M▲ 10.8% | 1.18B▲ 28.7% | 1.07B▲ 0% |
Operating Margin % | 18.78% | 18.37% | 17.81% | 18.82% | 16.86% | 9.79% | 11.19% | 12.91% | 16.6% | 15.9% |
Operating Income Growth % | 5.06% | 0.27% | -1.6% | 14.27% | -2.13% | -43.78% | 18.82% | 10.76% | 28.71% | - |
EBITDA | 1.28B | 1.29B | 1.29B | 1.44B | 1.45B | 920M | 1.06B | 1.15B | 1.4B | 1.3B |
EBITDA Margin % | 21.51% | 21.1% | 20.74% | 21.48% | 19.72% | 12.95% | 14.39% | 16.23% | 19.68% | 19.25% |
EBITDA Growth % | 4.22% | 0.54% | -0.23% | 12.02% | 0.28% | -36.46% | 15.54% | 8.28% | 21.46% | -0.46% |
D&A (Non-Cash Add-back) | 163M | 167M | 182M | 179M | 210M | 224M | 236M | 235M | 219M | 226M |
EBIT | 1.11B | 1.13B | 1.11B | 1.28B | 993M | 704M | 341M | 501M | 1.18B | 1.1B |
Net Interest Income | -78M | -73M | -88M | -91M | -88M | -92M | -87M | -80M | -92M | -101M |
Interest Income | 4M | 6M | 3M | 2M | 5M | 5M | 16M | 23M | 9M | 5M |
Interest Expense | 82M | 79M | 91M | 93M | 93M | 97M | 103M | 103M | 101M | 106M |
Other Income/Expense | -89M | -71M | -83M | -80M | -338M | -89M | -589M | -518M | -101M | -87M |
Pretax Income | 1.03B▲ 0% | 1.05B▲ 2.0% | 1.02B▼ 2.8% | 1.19B▲ 15.7% | 900M▼ 24.1% | 607M▼ 32.6% | 238M▼ 60.8% | 398M▲ 67.2% | 1.08B▲ 170.9% | 988M▲ 0% |
Pretax Margin % | 17.29% | 17.21% | 16.48% | 17.63% | 12.26% | 8.54% | 3.22% | 5.61% | 15.17% | 14.62% |
Income Tax | 330M | 231M | 204M | 246M | 181M | 136M | 77M | 106M | 254M | 218M |
Effective Tax Rate % | 31.95% | 21.92% | 19.92% | 20.76% | 20.11% | 22.41% | 32.35% | 26.63% | 23.56% | 22.06% |
Net Income | 701M▲ 0% | 823M▲ 17.4% | 820M▼ 0.4% | 939M▲ 14.5% | 710M▼ 24.4% | 462M▼ 34.9% | 149M▼ 67.7% | 280M▲ 87.9% | 810M▲ 189.3% | 756M▲ 0% |
Net Margin % | 11.74% | 13.44% | 13.2% | 13.97% | 9.67% | 6.5% | 2.02% | 3.95% | 11.4% | 11.18% |
Net Income Growth % | 8.18% | 17.4% | -0.36% | 14.51% | -24.39% | -34.93% | -67.75% | 87.92% | 189.29% | 8.93% |
Net Income (Continuing) | 703M | 823M | 820M | 939M | 719M | 471M | 161M | 292M | 824M | 770M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 181M | 173M | 168M | 164M | 161M | 159M |
EPS (Diluted) | 5.33▲ 0% | 6.25▲ 17.3% | 6.32▲ 1.1% | 7.35▲ 16.3% | 5.58▼ 24.1% | 3.73▼ 33.2% | 1.20▼ 67.8% | 2.25▲ 87.5% | 6.52▲ 189.8% | 6.21▲ 0% |
EPS Growth % | 8.33% | 17.26% | 1.12% | 16.3% | -24.08% | -33.15% | -67.83% | 87.5% | 189.78% | 10.79% |
EPS (Basic) | 5.43 | 6.37 | 6.42 | 7.46 | 5.65 | 3.75 | 1.21 | 2.25 | 6.56 | - |
Diluted Shares Outstanding | 131.57M | 131.58M | 129.79M | 127.67M | 127.3M | 123.91M | 124.18M | 124.8M | 124.29M | 121.79M |
Basic Shares Outstanding | 128.95M | 129.29M | 127.73M | 125.83M | 125.57M | 123.11M | 123.59M | 124.17M | 123.53M | 121.36M |
Dividend Payout Ratio | 58.77% | 54.68% | 59.76% | 56.76% | 78.59% | 123.59% | 391.28% | 212.5% | 74.32% | - |
CLX Balance Sheet
The Clorox Company (CLX) balance sheet — assets, liabilities & shareholders' equity
| Metric | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 1.51B | 1.31B | 1.3B | 2.02B | 1.83B | 1.73B | 1.83B | 1.62B | 1.61B | 2.65B |
Cash & Short-Term Investments | 418M | 131M | 111M | 871M | 319M | 183M | 367M | 202M | 167M | 1.19B |
Cash Only | 418M | 131M | 111M | 871M | 319M | 183M | 367M | 202M | 167M | 1.19B |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 565M | 600M | 631M | 648M | 604M | 681M | 688M | 695M | 821M | 671M |
Days Sales Outstanding | 34.53 | 35.76 | 37.06 | 35.19 | 30.03 | 34.97 | 33.99 | 35.76 | 42.18 | 38.69 |
Inventory | 459M | 506M | 512M | 454M | 752M | 755M | 696M | 637M | 523M | 588M |
Days Inventory Outstanding | 50.66 | 53.38 | 53.35 | 45.19 | 65.98 | 59.7 | 56.23 | 57.15 | 48.82 | 55.12 |
Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 77M | 88M | 97M | 205M |
Total Non-Current Assets | 3.06B | 3.75B | 3.81B | 4.19B | 4.5B | 4.43B | 4.12B | 4.13B | 3.95B | 3.79B |
Property, Plant & Equipment | 931M | 996M | 1.03B | 1.39B | 1.63B | 1.68B | 1.69B | 1.68B | 1.6B | 1.59B |
Fixed Asset Turnover | 6.42x | 6.15x | 6.01x | 4.82x | 4.49x | 4.24x | 4.37x | 4.23x | 4.44x | 4.24x |
Goodwill | 1.2B | 1.6B | 1.59B | 1.58B | 1.57B | 1.56B | 1.25B | 1.23B | 1.23B | 1.23B |
Intangible Assets | 722M | 929M | 912M | 894M | 918M | 884M | 712M | 681M | 566M | 49M |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 210M | 222M | 274M | 328M | 378M | 315M | 462M | 545M | 558M | 917M |
Total Assets | 4.57B▲ 0% | 5.06B▲ 10.6% | 5.12B▲ 1.1% | 6.21B▲ 21.4% | 6.33B▲ 1.9% | 6.16B▼ 2.8% | 5.95B▼ 3.5% | 5.75B▼ 3.3% | 5.56B▼ 3.3% | 6.44B▲ 0% |
Asset Turnover | 1.31x | 1.21x | 1.21x | 1.08x | 1.16x | 1.15x | 1.24x | 1.23x | 1.28x | 1.17x |
Asset Growth % | 1.22% | 10.65% | 1.11% | 21.44% | 1.95% | -2.78% | -3.46% | -3.26% | -3.3% | 14.67% |
Total Current Liabilities | 1.81B | 1.2B | 1.44B | 1.42B | 2.06B | 1.78B | 1.92B | 1.57B | 1.92B | 3.15B |
Accounts Payable | 501M | 507M | 507M | 575M | 930M | 960M | 1.02B | 950M | 838M | 0 |
Days Payables Outstanding | 55.3 | 53.48 | 52.83 | 57.23 | 81.6 | 75.91 | 82.48 | 85.24 | 78.23 | 66.38 |
Short-Term Debt | 804M | 199M | 396M | 0 | 300M | 237M | 50M | 4M | 4M | 1.68B |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 162M | 154M | 158M | 288M | 219M | 176M | 262M | 190M | 179M | 1.48B |
Current Ratio | 0.84x | 1.09x | 0.91x | 1.42x | 0.89x | 0.97x | 0.95x | 1.03x | 0.84x | 0.84x |
Quick Ratio | 0.58x | 0.67x | 0.55x | 1.10x | 0.52x | 0.54x | 0.59x | 0.63x | 0.57x | 0.65x |
Cash Conversion Cycle | 29.89 | 35.66 | 37.58 | 23.15 | 14.41 | 18.76 | 7.73 | 7.68 | 12.78 | 27.43 |
Total Non-Current Liabilities | 2.22B | 3.13B | 3.12B | 3.89B | 3.69B | 3.65B | 3.64B | 3.69B | 3.16B | 3.19B |
Long-Term Debt | 1.39B | 2.28B | 2.29B | 2.78B | 2.48B | 2.47B | 2.48B | 2.48B | 2.48B | 2.81B |
Capital Lease Obligations | 0 | 0 | 0 | 278M | 301M | 314M | 310M | 334M | 305M | 591M |
Deferred Tax Liabilities | 61M | 72M | 50M | 62M | 67M | 66M | 28M | 22M | 20M | 82M |
Other Non-Current Liabilities | 770M | 778M | 780M | 767M | 834M | 791M | 825M | 848M | 351M | 356M |
Total Liabilities | 4.03B | 4.33B | 4.56B | 5.3B | 5.74B | 5.43B | 5.56B | 5.26B | 5.08B | 6.34B |
Total Debt | 2.19B | 2.48B | 2.68B | 3.12B | 3.17B | 3.1B | 2.92B | 2.9B | 2.88B | 4.49B |
Net Debt | 1.78B | 2.35B | 2.57B | 2.25B | 2.85B | 2.92B | 2.56B | 2.7B | 2.71B | 3.3B |
Debt / Equity | 4.05x | 3.42x | 4.80x | 3.44x | 5.35x | 4.26x | 7.54x | 5.90x | 5.98x | 48.76x |
Debt / EBITDA | 1.71x | 1.92x | 2.08x | 2.16x | 2.19x | 3.37x | 2.75x | 2.52x | 2.06x | 3.45x |
Net Debt / EBITDA | 1.38x | 1.82x | 2.00x | 1.56x | 1.97x | 3.17x | 2.41x | 2.35x | 1.94x | 2.54x |
Interest Coverage | 13.60x | 14.24x | 12.25x | 13.74x | 10.68x | 7.26x | 3.31x | 4.86x | 11.67x | 10.38x |
Total Equity | 542M▲ 0% | 726M▲ 33.9% | 559M▼ 23.0% | 908M▲ 62.4% | 592M▼ 34.8% | 729M▲ 23.1% | 388M▼ 46.8% | 492M▲ 26.8% | 482M▼ 2.0% | 92M▲ 0% |
Equity Growth % | 82.49% | 33.95% | -23% | 62.43% | -34.8% | 23.14% | -46.78% | 26.8% | -2.03% | -163.08% |
Book Value per Share | 4.12 | 5.52 | 4.31 | 7.11 | 4.65 | 5.88 | 3.12 | 3.94 | 3.88 | 0.76 |
Total Shareholders' Equity | 542M | 726M | 559M | 908M | 411M | 556M | 220M | 328M | 321M | -67M |
Common Stock | 159M | 159M | 159M | 159M | 131M | 131M | 131M | 131M | 131M | 131M |
Retained Earnings | 2.44B | 2.8B | 3.15B | 3.57B | 1.04B | 1.05B | 583M | 250M | 432M | 223M |
Treasury Stock | -2.44B | -2.66B | -3.19B | -3.31B | -1.4B | -1.35B | -1.25B | -1.19B | -1.4B | 0 |
Accumulated OCI | -543M | -547M | -602M | -640M | -546M | -479M | -493M | -155M | -157M | -152M |
Minority Interest | 0 | 0 | 0 | 0 | 181M | 173M | 168M | 164M | 161M | 159M |
CLX Cash Flow Statement
The Clorox Company (CLX) cash flow — operating, investing & free cash flow history
| Metric | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 868M | 974M | 992M | 1.55B | 1.28B | 786M | 1.16B | 695M | 981M | 576M |
Operating CF Margin % | 14.53% | 15.9% | 15.96% | 23% | 17.38% | 11.06% | 15.67% | 9.8% | 13.81% | - |
Operating CF Growth % | 11.57% | 12.21% | 1.85% | 55.85% | -17.46% | -38.4% | 47.33% | -39.98% | 41.15% | -141.33% |
Net Income | 703M | 823M | 820M | 939M | 719M | 471M | 161M | 292M | 824M | 756M |
Depreciation & Amortization | 163M | 166M | 180M | 180M | 211M | 224M | 236M | 235M | 219M | 226M |
Stock-Based Compensation | 51M | 53M | 43M | 50M | 50M | 52M | 73M | 74M | 81M | 66M |
Deferred Taxes | -35M | -23M | -20M | -2M | -32M | 5M | -149M | -100M | -18M | 133M |
Other Non-Cash Items | 30M | 44M | -29M | 30M | 339M | 133M | 483M | 435M | 86M | -438M |
Working Capital Changes | -47M | -88M | -2M | 349M | -11M | -99M | 354M | -241M | -211M | -173M |
Change in Receivables | -1M | -24M | -32M | -27M | 82M | -84M | -13M | -34M | -145M | -216M |
Change in Inventory | -19M | -21M | -7M | 50M | -282M | -18M | 58M | 55M | 63M | 53M |
Change in Payables | -34M | -47M | 17M | 291M | 311M | -47M | 157M | -140M | -124M | -49M |
Cash from Investing | -205M | -859M | -196M | -252M | -452M | -229M | -223M | -175M | -94M | -196M |
Capital Expenditures | -231M | -194M | -206M | -254M | -331M | -251M | -228M | -212M | -220M | -196M |
CapEx % of Revenue | 3.87% | 3.17% | 3.32% | 3.78% | 4.51% | 3.53% | 3.09% | 2.99% | 3.1% | 2.9% |
Acquisitions | 0 | -681M | 0 | 0 | -85M | 0 | 0 | 17M | 128M | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 26M | 16M | 10M | 2M | -36M | 22M | 5M | 20M | -2M | 0 |
Cash from Financing | -645M | -399M | -815M | -523M | -1.39B | -689M | -753M | -655M | -924M | 578M |
Debt Issued (Net) | -125M | 277M | 189M | 96M | 0 | -83M | -188M | -45M | 0 | 253M |
Equity Issued (Net) | -108M | -226M | -514M | -86M | -802M | -20M | 33M | 1M | -306M | -79M |
Dividends Paid | -412M | -450M | -490M | -533M | -558M | -571M | -583M | -595M | -602M | -602M |
Share Repurchases | -183M | -271M | -661M | -248M | -905M | -25M | 0 | 0 | -332M | -61M |
Other Financing | 0 | 0 | 0 | 0 | -31M | -15M | -15M | -16M | -16M | 1.01B |
Net Change in Cash | 17M▲ 0% | -287M▼ 1788.2% | -21M▲ 92.7% | 766M▲ 3747.6% | -555M▼ 172.5% | -138M▲ 75.1% | 182M▲ 231.9% | -161M▼ 188.5% | -37M▲ 77.0% | 958M▲ 0% |
Free Cash Flow | 637M▲ 0% | 780M▲ 22.4% | 786M▲ 0.8% | 1.29B▲ 64.4% | 945M▼ 26.9% | 535M▼ 43.4% | 930M▲ 73.8% | 483M▼ 48.1% | 761M▲ 57.6% | 380M▲ 0% |
FCF Margin % | 10.66% | 12.74% | 12.65% | 19.22% | 12.87% | 7.53% | 12.59% | 6.81% | 10.71% | 5.62% |
FCF Growth % | 5.12% | 22.45% | 0.77% | 64.38% | -26.86% | -43.39% | 73.83% | -48.06% | 57.56% | -52.56% |
FCF per Share | 4.84 | 5.93 | 6.06 | 10.12 | 7.42 | 4.32 | 7.49 | 3.87 | 6.12 | 3.12 |
FCF Conversion (FCF/Net Income) | 1.24x | 1.18x | 1.21x | 1.65x | 1.80x | 1.70x | 7.77x | 2.48x | 1.21x | 0.50x |
Interest Paid | 78M | 75M | 87M | 89M | 89M | 89M | 99M | 102M | 97M | 0 |
Taxes Paid | 347M | 245M | 207M | 241M | 303M | 100M | 73M | 347M | 264M | 0 |
CLX Key Ratios
The Clorox Company (CLX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 167.1% | 129.81% | 127.63% | 128.02% | 94.67% | 69.95% | 26.68% | 63.64% | 166.32% | 404.82% |
Return on Invested Capital (ROIC) | 37.18% | 31.27% | 26.74% | 30.17% | 28.14% | 14.73% | 18.81% | 22.39% | 27.68% | 25.47% |
Gross Margin | 44.63% | 43.5% | 43.63% | 45.44% | 43.33% | 35.05% | 38.86% | 42.65% | 44.96% | 43.77% |
Net Margin | 11.74% | 13.44% | 13.2% | 13.97% | 9.67% | 6.5% | 2.02% | 3.95% | 11.4% | 11.18% |
Debt / Equity | 4.05x | 3.42x | 4.80x | 3.44x | 5.35x | 4.26x | 7.54x | 5.90x | 5.98x | 48.76x |
Interest Coverage | 13.60x | 14.24x | 12.25x | 13.74x | 10.68x | 7.26x | 3.31x | 4.86x | 11.67x | 10.38x |
FCF Conversion | 1.24x | 1.18x | 1.21x | 1.65x | 1.80x | 1.70x | 7.77x | 2.48x | 1.21x | 0.50x |
Revenue Growth | 3.68% | 2.53% | 1.47% | 8.16% | 9.22% | -3.19% | 3.97% | -4.01% | 0.16% | -3.69% |
Related:CLX Dividend History·CLX Revenue History·CLX Price History·CLX P/E History·CLX Financial Ratios·CLX Institutional Holders
CLX SEC Filings & Documents
The Clorox Company (CLX) SEC filings — annual & quarterly reports (10-K, 10-Q)
CLX Frequently Asked Questions
The Clorox Company (CLX) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
The Clorox Company (CLX) reported $6.76B in revenue for fiscal year 2025. This represents a 205% increase from $2.22B in 1996.
The Clorox Company (CLX) grew revenue by 0.2% over the past year. Growth has been modest.
Yes, The Clorox Company (CLX) is profitable, generating $756.0M in net income for fiscal year 2025 (11.4% net margin).
Dividend & Returns
Yes, The Clorox Company (CLX) pays a dividend with a yield of 5.06%. This makes it attractive for income-focused investors.
The Clorox Company (CLX) has a return on equity (ROE) of 166.3%. This is excellent, indicating efficient use of shareholder capital.
The Clorox Company (CLX) generated $380.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.